Expanded Access of Adagrasib (MRTX849) in Patients With Advanced Solid Tumors Who Have a KRAS G12C Mutation
Clinical trial NCT05162443 · APPROVED_FOR_MARKETING
Trial details
- NCT number
- NCT05162443
- Sponsor
- Bristol-Myers Squibb
- Status
- APPROVED_FOR_MARKETING
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.